Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Basal Cell 6 Lung Neoplasms 4 Skin Neoplasms 2 Precancerous Conditions 2 Pancreatic Neoplasms 2 Neoplasms 2 Keratosis, Actinic 2 Urologic Neoplasms 1 Urinary Bladder Neoplasms 1 Telangiectasis 1 Stomatitis 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Rosacea 1 Recurrent respiratory papillomatosis 1 Prostatic Neoplasms 1 Port-Wine Stain 1 Pancreatic Intraductal Neoplasms 1 Non-melanoma Skin Cancer 1 Nevus, Pigmented 1 Neoplasm Metastasis 1 Nasopharyngeal Neoplasms 1 Mouth Neoplasms 1 Mouth Diseases 1 Mixed Tumor, Malignant 1 Mesothelioma, Malignant 1 Melanoma 1 Lichen Planus, Oral 1 Leukoplakia, Oral 1 Kidney Neoplasms 1

Interventions

Cisplatin 24 Gemcitabine 16 Radiotherapy, Intensity-Modulated 14 Fluorouracil 7 Radiotherapy 5 Docetaxel 5 pembrolizumab 4 Surveys and Questionnaires 4 Carboplatin 4 Bevacizumab 4 toripalimab 3 spartalizumab 3 camrelizumab 3 Induction Chemotherapy 3 Endostatins 3 Counseling 3 Cetuximab 3 Acupuncture Therapy 3 sintilimab 2 nimotuzumab 2 endostar protein 2 apatinib 2 Psychiatric Rehabilitation 2 Paclitaxel 2 Nivolumab 2 Immunohistochemistry 2 Drug Therapy 2 Chemoradiotherapy 2 Celecoxib 2 Capecitabine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Nasopharyngeal Neoplasms × Tomography, Optical Coherence × Clear all

NCT04724590 2021-01-26

ORONIN

Istanbul University - Cerrahpasa

Phase NA Unknown

Nasopharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡